Search Term:

*


April 8, 2018: Product identified as key to making a great contribution to the advancement of upstream and downstream bioprocessing

September 11, 2018: Pall and Aetos partner to combine bioreactors, mixing and storage, and downstream technologies with cell lines and manufacturing processes for expedited biosimilars development

September 24, 2018: New collaboration to see G-CON PODs customized with Pall technologies, addressing customer demand for higher efficiencies, while enjoying more flexibility through scale-out and localization of manufacturing

October 5, 2016: New collaboration to deliver complete solutions for industrial-scale bioreactor expansion of human Mesenchymal Stem/Stromal Cells (hMSCs), to accelerate product development, reduce clinical translation timelines and streamline the commercialization pathway for stem cell-based therapies

July 17, 2018: Agreement will meet increased demand for more targeted and personalized medicines currently driving growth and development in the mAb manufacturing market and offer a complete solution to customers

January 18, 2016: New chromatography media (sorbent) will offer high dynamic binding capacity, good flow performance and optimal alkali stability for reuse

September 11, 2015: Pall manufacturing facility in Ilfracombe, UK is singled out for its exceptional health and safety management systems

October 4, 2016: Multiple breakthrough technologies announced to enable integrated, process-scale continuous production of biotherapies in single-use format

April 26, 2016: This new product will eliminate reliance on centrifugation for cell culture clarification, reducing buffer requirements by around 75%, and create a continuous feed stream for direct integration with Pall's full portfolio

October 13, 2016: Introducing a reliable, robust, universal single-use fluid handling connector - a genderless technology for the sterile connection of two fluid paths even in uncontrolled environments

July 26, 2017: Announcing a new bioreactor control system - the first in Pall's next generation of unifying technologies for a seamless, fully controlled, and value-based user experience

December 13, 2017: Several recent and upcoming high-profile partnership announcements announced to help advance the drug production industry through key technology innovations

September 28, 2016: A series of new product launches being planned for Biotech Week Boston in October

October 20, 2015: A total of four new and updated products to be unveiled at the event, with Pall experts on hand to discuss advances that continuously improve bioprocesses for customers

November 9, 2017: New training courses starting early 2018 focused on continuous bioprocessing advances will detail the state of the industry, and the advantages and practical implications of transitioning from batch to semi- or fully-continuous bioprocess methodologies

June 15, 2015: Announcing Pall's signing of an exclusive license for acoustic wave separation (AWS), a disruptive technology from FloDesign Sonics (FDS) for cell culture clarification for both fed-batch and perfusion applications

October 5, 2016: Launch of new product designed for linear scale-up of an existing PD-scale continuous purification process to a GMP-compliant process-scale continuous purification using feedstreams derived from fed batch bioreactors of up to 2000 liter volume

December 18, 2018: New centre to give Pall customers options ranging from batch to single use and continuous bioprocessing solutions, and to provide technology solutions that meet current needs, while offering some of the most progressive technological solutions for the future

October 2, 2018: New centre will work to enhance drug production and empower the future workforce, reinforcing Pall's commitment to continuously improve bioprocesses through strategic partnerships

December 9, 2016: Cadence Acoustic Separator wins the BioProcess International (BPI) Award for best downstream processing application